If you're a biotechnology company seeking global opportunities in areas of business development, partnerships and licencing, sales, marketing and distribution, here's some great reasons why you should join us on our trade mission to the BIO2018.
1. World’s premier life sciences event
The BIO International Convention (BIO) is the largest global event for the biotechnology industry, attracting the biggest names in biotech, offering key networking and partnering opportunities, and providing insights and inspiration on the major trends affecting the industry.
- BIO has hosted Heads of State, Deputy Prime Ministers, Federal Ministers, Ambassadors, as well as heads of regulatory agencies, patenting offices, and national reimbursement authorities in all of its previous conventions.
- BIO's esteemed government participants receive special opportunities to meet and interact with CEOs and other senior executives attending BIO.
2. Record-breaking attendees
In 2017, the convention attracted 16,123 attendees from 74 countries, 48 American states, and more than 100 international and domestic public officials representing every channel of biotechnology.
- In 2018, BIO will host over 1800 exhibitors and more than 1500 education sessions.
- BIO represents companies of all sizes – 31 per cent of attendees are from companies with more than 500 employees and 44 per cent are from companies with fewer than 50 employees.
3. Networking opportunities and meetups
With unparalleled networking opportunities at your fingertips, the BIO International Convention hosts countless evening networking and partnering opportunities. With receptions and events happening throughout the convention, you'd be hard pressed to find a better place to network with the biotechnology industry's most influential leaders.
4. Access to global biotech and pharma leaders via BIO One-on-One partnering system
The BIO One-on-One Partnering system provides the opportunity for biotechnology and pharmaceutical companies, academic research institutions and investors from around the world to schedule 30-minute face-to-face meetings to discuss potential partnerships. Meetings take place in the BIO Business Forum and the BIO Exhibition.
- 2017 saw more than 41,400 partnering meetings (up 16 per cent from the previous year) from 35,000 participating organisations.
5. Exposure to industry thought-leaders through BIO’s Education Sessions
BIO's education program covers the industry's most relevant and timely topics, providing the know-how you need to advance your business from the top leaders in biotech.
- Education tracks, select special programs, and super sessions are included in Convention Access and Education & Exhibition Access registration.
6. Boston – a powerhouse for industry growth
As the world’s epicentre of biotechnology innovation, Boston is home to nearly 1000 biotech companies, academic centres, hospitals and life science centres advancing breakthrough research and product development.
- The Victorian Government has advanced two historic partnership agreements with Boston’s Harvard affiliated Teaching Hospital, the Dana-Farber Cancer Institute, and the Boston Children’s Hospital.The agreements build on an existing agreement made in 2016 between Dana-Farber, and Victoria’s Peter MacCallum Cancer Centre, both world leaders in cancer research, prevention, treatment and care.
- These projects were finalised as part of a delegation to the USA to strengthen international ties between Victoria and some of the world’s most prestigious health and medical research institutions.
7. Our commitment to showcasing your company’s strengths and capabilities
Victorian Government will showcase your company’s strengths at BIO2018, providing your organisation with a variety of marketing opportunities, connection points and networking resources to support your participation at the convention.
- Victoria has significant strengths in a range of research and industry capabilities including infectious disease and diagnostics, cancer, neurology and regenerative medicine.
- Melbourne is also a leading international location and strategic hub in Asia-Pacific for new drug candidate identification, medicinal chemistry and drug optimisation, as well as clinical trials.